Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation

Annals of Neurology

Volumn 49, Issue 5, 2001, Pages 597-606

  Nelson, Karin B ^a   Grether, Judith K ^b   Croen, Lisa A ^b   Dambrosia, James M ^a   Dickens, Benjamin F ^c   Jelliffe, Laura L ^b   Hansen, Robin L ^d   Phillips, Terry M ^e  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b March of Dimes Birth Defects Foundation   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CALCITONIN GENE RELATED PEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; NERVE GROWTH FACTOR; NEUROPEPTIDE; NEUROTROPHIN; NEUROTROPHIN 3; NEUROTROPHIN 4; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

ARTICLE; AUTISM; CEREBRAL PALSY; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; NEWBORN; PRIORITY JOURNAL;

AUTISTIC DISORDER; FEMALE; HUMANS; INFANT, NEWBORN; MALE; MENTAL RETARDATION; NERVE GROWTH FACTORS; NEUROPEPTIDES;

EID: 0035021249     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.1024     Document Type: Article

References (72)

1. Filipek PA, Accardo PJ, Baranek GT, et al. The screening and diagnosis of autistic spectrum disorders. J Autism Dev Disord 1999;29:439-484.
2. Landgren M, Gillberg C, Stromland K. Goldenhar syndrome and autistic behavior. Dev Med Child Neurol 1992;34:999-1009
3. Stromland K, Nordin V, Miller M, et al. Autism in thalidomide embryopachy: a population study, Dev Med Child Neurol 1994;36:351-356
4. Rodier PM, Ingram JL, Tisdale B, et al. Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei. J Com Neurol 1996;370:247-261
5. Cox A, Klein K, Charman T, et al. Autism spectrum disorders at 20 and 42 months of age: stability of clinical and ADI-R diagnosis. J Child Psychol Psychiat 1999;40:719-732
6. Stone WL, Lee EB, Ashford L, Brissie J, Hepburn SL, Coonrod EE, Weiss BH. Can autism be diagnosed accurately in children under 3 years? J Child Psychol Psychiatry 1999;40:219-226
7. Bailey A, Le Couteur A, Gottesman I, et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 1995;25:63-77
8. Risch N, Spiker D, Lotspeich L, et al. A genomic screen of autism: evidence for a multilocus etiology. Am J Hum Genet 1999;65:493-507
9. Spiker D, Lotspeich L, Kraemer HC, et al. Genetics of autism: characteristics of affected and unaffected children from 37 multiplex families. Am J Med Genet 1994;54:27-35
10. Konstantareas MM, Homatidis S. Chromosomal abnormalities in a series of children with autistic disorder. J Autism Dev Disord 1999;29:275-285
11. Szatmari P. Heterogeneity and the genetics of autism. J Psychiatry Neurosci 1999;24:159-165
12. Bailey A, Palferman S, Heavey L, Le Couteur A. Autism: the phenotype in relatives. J Autism Dev Disord 1998;28:369-392
13. Bolton PF, Pickles A, Murphy M, Rutter M. Autism, affective and other psychiatric disorders: patterns of familial aggregation. Psychol Med 1998;28:385-395
14. Mahoney WJ, Szatmari P, MacLean JE, et al. Reliability and accuracy of differentiating pervasive developmental disorder subtypes. J Am Acid Child Adolesc Psychiatry 1998;37:278-285
15. Kemper TL, Bauman M. Neuropathology of infantile autism. J Neuropathol Exp Neurol 1998;57:645-652
16. Bailey A, Luthert P, Dean A, et al. A clinicopathological study of autism. Brain 1998;121:889-905.
17. Aylward EH, Minshew NJ, Goldstein G, et al. MRI volumes of amygdala and hippocampus in non-mentally retarded autistic adolescents and adults. Neurol 1999;53:2145-2150
18. Lindholm D, Hamner S, Zirrgiebel U. Neurotrophins and cerebellar development. Perspect Dev Neurobiol 1997;5:83-94
19. Morrison ME, Mason CA. Granule neuron regulation of Purkinje cell development: striking a balance between neurotrophin and glutamate signaling. J Neurosci 1998;18:3563-3573
20. Quartu M, Lai ML, Del Fiacco M. Neurotrophin-like immunoreactivity in the human hippocampal formation. Brain Res Bull 1999;48:375-382
21. Hayashi M, Mitsunage F, Ohira K, et al. Development of full-length Trk B-immunoreactive structures in the hippocampal formation of the macaque monkey. Anat Embryol 1999;199: 529-537
22. Jankowsky JL, Patterson PH. Cytokine and growth factor involvement in long-term potentiation. Mol Cell Neurosci 1999; 14:273-286
23. Lu B, Chow A. Neurotrophins and hippocampal synaptic transmission and plasticity. J Neurosci Res 1999;58:76-87
24. Maren S. Long-term potentiation in the amygdala: a mechanism for emotional learning and memory. Trends Neurosci 1999;22:561-567
25. Shors TJ, Matzel LD. Long-term potentiation: what's learning got ro do with it? Behav Brain Sci 1997;20:597-655
26. Grether JK, Cummins SK, Nelson KB. The California Cerebral Palsy Project. Paediatr Perinat Epidemiol 1992;6:339-351
27. Nelson KB, Dambrosia JM, Grether JK, Phillips TM. Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol 1998;44:665-675
28. Phillips TM, Krum JM. Recycling immunoaffinity chromatography for multiple analyte analysis in biological samples. J Chromatogr B Biomed Sci Appl 1998;715:55-63
29. Phillips TM, Dickens BF. Affinity and immunoaffinity purification techniques. Natiack, MA: Eaton Press, 2000
30. Shi H, Ma Y, Humphrey JH, Craft NE. Determination of vitamin A in dried human blood spots by high-performance capillary electrophoresis with laser-excited fluorescence detection. J Chromatogr B Biomed Sci Appl 1995;665:89-96
31. Pellegri G, Magistretti PJ, Martin J-L. VIP and PACAP potentiate the action of glutamate on BDNF expression in mouse cortical neurons. Eur J Neurosci 1998;10:272-280
32. Benson DL, Isakson PJ, Jones EG. In situ hybridization reveals VIP precursor mRNA-containing neurons in monkey and rat neocortex. Brain Res Mol Brain Res 1991;9:169-174
33. Vertongen P, Schiffmann SN, Gourlet P, Robberecht P. Autoradiographic visualization of the receptor subclasses for vasoactive intestinal peptide (VIP) in rat brain. Peptides 1997;18: 1547-1554
34. Gressens P, Hill JM, Gozes I, et al. Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos. Nature 1993;362:155-158
35. Gressens P, Paindaveine B, Hill JM, et al. Vasoactive intestinal peptide shortens both G1 and S phases of neural cell cycle in whole postimplantation cultured mouse emhryos. Eur J Neurosci 1998;10:1734-1742
36. Gressens P, Hill JHM, Paindaveine B, et al. Severe microcephaly induced by blockade of vasoactive intestinal peptide function in the primitive neuroepithelium of the mouse. J Clin Invest 1994;94:2020-2027
37. Wu JY, Henins KA, Gressens P, et al. Neurobehavioral development of neonatal mice following blockade of VIP during the early embryonic period. Peptides 1997;18:1131-1137
38. Gozes I, Bachar M, Bardea A, et al. Protection against developmental deficiencies by a lipophilic VIP analogue. Neurochem Res 1998;23:689-693
39. Zupan V, Nehlig A, Evrard P, Gressens P. Prenatal blockade of vasoactive intestinal peptide alters cell death and synaptic equipment in the murine neocortex. Pediatr Res 2000;47: 53-63
40. Lam KSL, Srivastava G, Tam S-P. Divergent effects of glucocorticoid on the gene expression of vasoactive intestinal peptide in the rat cerebral cortex and pituitary. Neuroendocrinology 1992;56:323-327
41. Glazner GW, Gressens P, Lee SJ, et al. Activity-dependent neurotrophic factor: a potent regulator of embryonic growth and development. Anat Embryol 1999;200:65-71
42. Blondel O, Collin C, McCarran B, et al. A glia-derived signal regulating neuronal differentiation. J Neurosci 2000;20:8012-8020
43. Ades AM, McCune SK, Crnic LS, et al. Vasoaccive intestinal peptide dysfunction associated with a segmental trisomy model of Down syndrome [abstr]. Pediatr Res 2000;47(2):80A
44. Spong CY, Lee SJ, McCune SK, et al. Maternal regulation of embryonic growth: the role of vasoactive intestinal peptide. Endocrinology 1999;140:917-24
45. 131I-VIP in rat using gamma camera. Nucl Med Biol 1999;26:931-936
46. Martinez C, Delgado M, Abad C, et al. Regulation of VIP production and secretion by murine lymphocytes. J Neuroimmunol 1999;93:126-138
47. Meyer M, Fluge T, Kruhoffer M, Forssmann WG. Basic aspects of vasorelaxant and bronchodilating peptides in clinical use: urodilatin (INN: Ularitide), VIP, and PACAP. Ann NY Acad Sci 1996;805:443-461
48. Bellinger DL, Lorton D, Brouxhon S, et al. The significance of vasoactive intestinal polypeptide (VIP) in immunomodulation. Adv Neuroimmunol 1996;6:5-27
49. Pozo D, Delgado M, Martinez C, et al. Immunobiology of vasoactive intestinal peptide (VIP). Immunol Today 2000;21:7-11
50. Holst N, Oian P, Aune B, et al. Increased plasma levels of vasoactive intestinal polypeptide in pre-eclampsia. Br J Obstet Gynaecol 1991;98:803-806
51. Ko FJ, Chiang CH, Liu WJ, Chiang W. Somatostatin, substance P, prolactin and vasoactive intestinal peptide levels in serum and cerebrospinal fluid of children with seizure disorders. Kaohsiung J Med Sci 1991;7:391-397
52. Romualdi P, Lesa G, Donatini A, et al. Alterations in vasoactive intestinal polypeptide-related peptides after pentylenetetrazole-induced seizures in rat brain. Eur J Pharmacol 1992;229:149-153
53. Minichiello L, Korte M, Wolfer D, et al. Essential role for TrkB receptors in hippocampus-mediated learning. Neuron 1999;24:401-414
54. Dreyfus CF. Neurotransmitters and neurotrophins collaborate to influence brain development. Perspect Devel Neurobiol 1998;5:389-399
55. Berninger B, Poo M-M. Exciting neurotrophins. Nature 1999; 401:862-863
56. Seil FJ. BDNF and NT-4, but not NT-3, promote development of inhibitory synapses in the absence of neuronal activity. Brain Res 1999;818:561-564.
57. Lu B, Chow A. Neurotrophins and hippocampal synaptic transmission and plasticity. J Neurosci Res 1999;58:76-87.
58. Desai NS, Rutherford LC, Turrigiano GG. BDNF regulates the intrinsic excitability of cortical neurons. Learn Mem 1999;6: 284-291
59. Black IB. Trophic regulation of synaptic plasticity. J Neurobiol 1999;41:108-118.
60. Mossner R, Daniel S, Albert D, et al. Serotonin transporter function is modulated by brain-derived neurotrophic factor (BDNF) but not nerve growth factor (NGF). Neurochem Int 2000;36:197-202
61. Croll SD, Suri C, Compton DL, et al. Brain-derived neurotrophic factor transgenic mice exhibit passive avoidance deficits, increased seizure severity and in vitro hyperexcitability in the hippocampus and entorhinal cortex. Neuroscience 1999;93: 1491-1506
62. Elia M, Ferri, Musumeci SA, et al. Sleep in subjects with autistic disorder: a neurophysiological and psychological study. Brain Dev 2000;22:88-92
63. Horvath K, Papadimitriou JC, Rabsztyn A, et al. Gastrointestinal abnormalities in children with autistic disorder. J Pediatr 1999;135:559-563
64. Kohlmeier KA, Reiner PB. Vasoactive intestinal polypeptide excites medial pontine reticular formation neurons in the brain-stem rapid eye movements sleep-induction zone. J Neurosci 1999;19:4073-4081
65. Hughes PE, Elexi T, Walton M, et al. Activity and injury-dependent expression of inducible transcription factors, growth factors, and apoptosis-related genes within the central nervous system. Prog Neurobiol 1999;57:421-450
66. Penschuck S, Paysan J, Giorgetta O, Fritschy JM. Activity-dependent regulation of GABAA receptors. Ann NY Acad Sci 1999;868:654-656
67. Vig S, Jedrysek E. Autistic features in young children with significant cognitive impairment: autism or mental retardation? J Autism Dev Disord 1999;29:235-248
68. Lord C, Pickles A. Language level and nonverbal social-communicative behaviors in autistic and language-delayed children. J Am Acad Child Adolesc Psychiatry 1996;35:1542-1550
69. Stevenson RE, Schroer RJ, Skinner C, et al. Autism and macrocephaly. Lancet 1997;349:1744-1745
70. Lainhart JE, Piven J, Wzorek M, et al. Macrocephaly in children and adults with autism. J Am Acad Child Adolesc Psychiatry 1997;36:282-290
71. Broman S, Nichols PL, Shaughnessy P, Kennedy W. Retardation in young children. Hillsdale, NJ: Erlbaum Associates, 1987
72. Flint J. The genetic basis of cognition. Brain 1999;122:2015-2032.